How can we help you?

AJAY GAUTAM, Head of R&D External Collaboration in Emerging Markets at AstraZeneca

will give a presentation in our Special Focus Session on Planning for growth via R&D, M&A and strategic alliances. Mr. Gautam will inform the audience about AstraZeneca’s R&D global restructuring programme and its externalisation efforts in emerging markets (23rd May, 15:30)

Invited with the support of company AKRIKHIN

RITA BYINGTON, Advisor from the Health Production and Innovation Department (Fiocruz) at the Ministry of Health of Brazil

Presntation "Brazil, ways forward in ensuring access to medicines" will take place on 22nd May in Session Two: 360º REGULATORY REVIEW (part II). Read more 

  Keynote Presentation: Innovative financing to expand access to affordable quality care
Rifat Atun, Professor of International Health Management, Imperial College London

2 SPOTLIGHT INTERVIEWS

 Jostein Davidsen, Head of Emerging Markets, Takeda Company and Area Head of Russia/CIS, Nycomed: a Takeda Company 

  David Panikashvili, President, Pharmaceutical Group ROSTA

1. ACHIEVING COMMERCIAL EXCELLENCE IN PHARMA MARKET
Topics to be discussed: Effective product portfolio and life-cycle management, measuring sales team’s efficiency and qualify sizing decisions, working in the market with restrictions on interaction with healthcare professionals

2. REGULATORY AFFAIRS AND COMPLIANCE DAY
Topic for discussion:  Product Approval and Registration, Clinical Trials, Harmonisation and Regulatory Framework, Development and Quality Assurance, Pharmacovigilance and Compliance

Download Regulatory Affairs and Compliance Focus Day programme